RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Analyst Ratings
USA - NASDAQ:RANI - US7530181004 - Common Stock
1.82 USD
-0.27 (-12.92%)
1.87 USD
+0.05 (+2.75%)
ChartMill assigns a Buy % Consensus number of 82% to RANI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.93. This target is 390.38% above the current price.
RANI was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about RANI.
In the previous month the buy percentage consensus was at a similar level.
RANI was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | Maxim Group | Maintains | Buy -> Buy |
| 2025-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-02 | Oppenheimer | Initiate | Outperform |
| 2024-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-14 | Maxim Group | Initiate | Buy |
| 2024-06-13 | Rodman & Renshaw | Initiate | Buy |
| 2024-05-09 | BTIG | Maintains | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-06 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-11 | UBS | Initiate | Buy |
| 2022-07-27 | HC Wainwright & Co. | Initiate | Buy |
| 2022-06-13 | Wedbush | Initiate | Outperform |
| 2021-08-25 | BTIG | Initiate | Buy |
RANI THERAPEUTICS HOLDINGS-A / RANI FAQ
What do analysts expect the price target to be for RANI THERAPEUTICS HOLDINGS-A (RANI)?
9 analysts have analysed RANI and the average price target is 8.93 USD. This implies a price increase of 390.38% is expected in the next year compared to the current price of 1.82.
Can you provide the consensus rating for RANI THERAPEUTICS HOLDINGS-A stock?
The consensus rating for RANI THERAPEUTICS HOLDINGS-A (RANI) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for RANI THERAPEUTICS HOLDINGS-A stock?
The number of analysts covering RANI THERAPEUTICS HOLDINGS-A (RANI) is 9.